Switching from subcutaneous to intravenous erythropoietin α in haemodialysis patients requires a major dose increaseGALLIFORD, Jack W; MALASANA, Rao; FARRINGTON, Ken et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 9, pp 1956-1962, issn 0931-0509, 7 p.Article

Kidney Transplantation With Minimized Maintenance: Alemtuzumab Induction With Tacrolimus Monotherapy—An Open Label, Randomized TrialCHAN, Kakit; TAUBE, David; HAKIM, Nadey et al.Transplantation. 2011, Vol 92, Num 7, pp 774-780, issn 0041-1337, 7 p.Article

ABO Incompatible Living Renal Transplantation With a Steroid Sparing Protocol. CommentaryMAI, Martin L; AHSAN, Nasimul; MCLEAN, Adam et al.Transplantation. 2008, Vol 86, Num 7, issn 0041-1337, 897-898, 901-906 [8 p.]Article

Peritubular Capillary Basement Membrane Multilayering on Electron Microscopy: A Useful Marker of Early Chronic Antibody-Mediated DamageROUFOSSE, Candice A; SHORE, Ian; TAUBE, David et al.Transplantation. 2012, Vol 94, Num 3, pp 269-274, issn 0041-1337, 6 p.Article

De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant GlomerulopathyWILLICOMBE, Michelle; BROOKES, Paul; TAUBE, David et al.Transplantation. 2012, Vol 94, Num 2, pp 172-177, issn 0041-1337, 6 p.Article

Antibody-Mediated Rejection After Alemtuzumab Induction: Incidence, Risk Factors, and Predictors of Poor OutcomeWILLICOMBE, Michelle; ROUFOSSE, Candice; BROOKES, Paul et al.Transplantation. 2011, Vol 92, Num 2, pp 176-182, issn 0041-1337, 7 p.Article